Advertisement

Topics

Companies Related to "Apomorphine Injection Parkinson Disease" [Most Relevant Company Matches] - Page: 2 [Advanced Search Results] RSS

15:54 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Apomorphine Injection Parkinson Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Apomorphine Injection Parkinson Disease" Companies 26–50 of 2,800+

Relevant

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...


Techpool Bio-pharma Co., Ltd.

Established in 1993, Techpool Bio-Pharma Co., Ltd. is one of the leading bio-pharma companys in China, with total assets of USD30 million and registered capital of USD11.7 million. We are specializing in R&D, manufacturing and marketing of bio-pharmaceutical products and currently export to Japan, Korea, India, Pakistan, Israel etc. We manufacture the following pharmaceutical products: Finished p...

Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease, brain tumors, transmissible spongiform encephalopathies, and Lewy Body diseases such as Parkinson's disease. Changes in disease-relevant proteins by altered expression, post-tr...


Mind-NRG

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barrier through a receptor-mediated transport to reach its target in the brain. Currently at the pre-clinical stage, NRG-101 is being developed to treat d...

Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics (PTI) is developing novel disease-modifying therapeutics that target the cellular pathways regulating protein folding, trafficking, and clearance. The Proteostasis Network (PN) is comprised of these interconnected cellular pathways and can become imbalanced by the cumulative effects of aging, disease, genetics and environmental fa...

Novogen

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (m...

Lantheus Medical Imaging, Inc. and NTP Radioisotopes

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in the field of diagnostic imaging provides a strong platform from which ...

The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research

Anida Pharma, Inc.

Anida is a biopharmaceutical company developing novel first-in-class therapies to treat Parkinson’s disease, amyotrophic lateral sclerosis (ALS; Lou Gehrig disease), other central nervous system disorders, and hearing loss. Our therapeutic concept is based on activating the body’s own homeostatic mechanisms to regulate inflammation, prevent ...

Yumanity Therapeutics

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Formed in 2014 by renowned biotech industry leader, Tony Coles, M.D., and protein folding science pioneer, Susan Lindquist, Ph.D., the company is initially focused on discovering disease-modifying therapies for patients with Alzheimer’s di...

Ypsomed AG

Our name reflects our expertise: “ipso” means “self” and “med” stands for medication. Hence our company name perfectly illustrates our core business: to market products and services which allow patients to administer their own medication in a safe, simple way. Our self-injection devices and our support and advisory services help millions of people, most of them diabetics, to enjoy the ...

Parkinson’s Institute and Clinical Center

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care, basic science research, and clinical research in one integrated model. Our unique freestanding organization directly connects research to patient care – from the “bench to ...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Our clinical focus is on Parkinson's disease and pain. We were established in 1999 as a spin-off from Pharmacia & Upjohn and are headquartered in Bresso, near Milan, Italy. We are conducting Phase III c...

Neurotech Pharmaceutical Inc

Neurotech Pharmaceutical Inc. is a core biotechnology company in South Korea , established in 1998.Neurotech seeks to discover, develop, and commercialize major pharmaceutical products to cure brain related diseases, such as stroke, Parkinson ' s disease, Alzheimer ' s disease, spinal cord injury, and glaucoma. Our business strategy is to understand mechanisms of degenerative and regenerative neur...

NeuroNova AB

NeuroNova is leading the development of therapeutic neurogenesis. Our drug development projects are aimed at stimulating processes in the brain that lead to the formation of new neurons. We believe therapeutic neurogenesis can revolutionize the treatment of several currently incurable neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, as well as certain orphan dru...

Guilford Pharmaceuticals Incorporated

Guilford Pharmaceuticals Inc. was founded in July 1993 by Scios Nova Inc., Dr. Solomon H. Snyder and Dr. Craig R. Smith to discover and develop novel pharmaceutical and biopolymer-based products that are intended to offer new and better treatments for serious medical conditions like Parkinson's disease, Alzheimer's disease, cancer and diabetic peripheral neuropathy. To focus its efforts, the compa...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

MEDRAD, Inc.

MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United St...

Texas Neurology, P.A.

Welcome to Texas Neurology Our Mission: "To serve our patients, physicians, colleagues and students by providing the highest quality of neurological care, consultative services and educational opportunities." Texas Neurology is committed to our patients by providing excellence in neurological care. Our doctors work closely with referring physicians to diagnose and treat disorders of the nervous sy...

Prestwick Pharmaceuticals, Inc.

Prestwick Pharmaceuticals, Inc, is a product-based, specialty pharmaceutical company engaged in the development and marketing of small molecule drugs for chronic diseases of the central nervous system (CNS). Following our founding in 2002, we rapidly acquired rights to a promising portfolio of small molecule drugs, all with unique attributes and targeting chronic CNS conditions not adequately serv...

Raleigh Neurology Associates, P.A.

Founded in 1983, Raleigh Neurology Associates, PA is a privately held medical practice and is one of the largest and most respected neurology practices in the nation. RNA provides comprehensive neurological treatment and care for over 250,000 people in the Triangle area. Specialties include: Headaches/Migraines, Sleep Disorders, Child Neurology, Neurodiagn...

TREVENTIS Corporation

TREVENTIS is headquartered in Southeastern Pennsylvania and has research operations in Halifax, Nova Scotia, Canada. The company is focused on the discovery and early stage development of disease- modifying small molecule drugs for Alzheimer’s and other protein misfolding diseases such as Parkinson’s and Huntington’s diseases. In addition to its ...

Pharmacia Biotech Incorporated

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injecti...

NeuroDerm Ltd

NeuroDerm is an emerging pharmaceutical company that develops therapeutic dermal patches for the treatment of CNS diseases. NeuroDerm's technology is based on proprietary reformulations of well established oral drugs whose low bio-availability is the major impediment to better efficacy. The company's lead product is ND0611, a revolutionary skin patch for the treatment of Parkinson's disease. O...

Hoefer Pharmacia Biotech Incorporated

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injecti...


More From BioPortfolio on "Apomorphine Injection Parkinson Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks